================================================================================
Q: Describe distinct roles of TP53 and BRCA1 in cancer biology.

# COMMENT
[TOOL SELECTION] Claude (Haiku) selected: ['uniprot_base', 'trait_function', 'trait_disease']

Answer:
TP53 and BRCA1 have distinct but complementary roles in cancer biology. TP53 functions as a tumor suppressor protein that acts as a transcriptional activator and guardian of the genome, responding to DNA damage by inducing cell cycle arrest or apoptosis. BRCA1 serves as an E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. While TP53 primarily acts through transcriptional regulation to prevent cancer development, BRCA1 functions through direct DNA repair mechanisms, particularly homologous recombination repair (HRR). BRCA1 coordinates diverse cellular pathways including DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability, and is required for appropriate cell cycle arrests after ionizing irradiation in both S-phase and G2 phase. Both proteins are critical tumor suppressors, but they operate through different molecular mechanisms - TP53 through transcriptional control and BRCA1 through direct DNA repair and protein ubiquitination.

Evidence:
  - E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage
  - The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability
  - Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle
  - Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2
  - Acts as a transcriptional activator
  - Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer
  - Cells lacking BRCA1 show defects in DNA repair by homologous recombination


